The estimated Net Worth of Jeff Himawan is at least $95 Milhão dollars as of 26 September 2023. Jeffrey Himawan owns over 32,161 units of Horizon Therapeutics Plc stock worth over $5,180,700 and over the last 18 years he sold HZNP stock worth over $89,300,886. In addition, he makes $521,332 as Independent Director at Horizon Therapeutics Plc.
Jeffrey has made over 10 trades of the Horizon Therapeutics Plc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 32,161 units of HZNP stock worth $446,073 on 26 September 2023.
The largest trade he's ever made was selling 3,450,000 units of Horizon Therapeutics Plc stock on 19 November 2014 worth over $41,572,500. On average, Jeffrey trades about 337,606 units every 171 days since 2007. As of 26 September 2023 he still owns at least 44,546 units of Horizon Therapeutics Plc stock.
You can see the complete history of Jeffrey Himawan stock trades at the bottom of the page.
Dr. Jeffrey Himawan, Ph.D. is Independent Director of the Company. Dr. Himawan has been a managing director of Essex Woodlands Health Ventures, a venture capital firm, since 2004. Prior to that, he was an adjunct partner at Essex Woodlands from 1999 to 2001, and he was a venture partner from 2001 to 2004. Dr. Himawan co-founded Seed-One Ventures, an early-stage venture capital firm, where he served as a managing director from 1996 to 2001. Dr. Himawan also currently serves on the boards of directors of Catalyst Biosciences, Inc. and MediciNova, Inc., each a public biopharma company, and on the board of directors of NexEos Diagnostics, Inc., a private biotechnology company.
As the Independent Director of Horizon Therapeutics Plc, the total compensation of Jeffrey Himawan at Horizon Therapeutics Plc is $521,332. There are 9 executives at Horizon Therapeutics Plc getting paid more, with Timothy Walbert having the highest compensation of $13,873,200.
Jeffrey Himawan is 55, he's been the Independent Director of Horizon Therapeutics Plc since 2007. There are 10 older and 12 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Jeff's mailing address filed with the SEC is C/O HORIZON THERAPEUTICS PLC,, 70 ST. STEPHEN?S GREEN, DUBLIN, L2, D02 E2X4.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over $454,905,275 worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth $58,823,653 . The most active insiders traders include Jeff Himawan, Woodlands Health Ventures F..., eJean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of $12,248,018. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth $351,691.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: